The Neurocoagulation Devices Market is expected to reach US$ 1,227 Million by 2030, registering a CAGR of 6.3%, driven by the increasing incidence of stroke

Acumen Research and Consulting

Acumen Research and Consulting

Acumen Research and Consulting recently published a report titled “Neurovascular Ablation Devices Market Forecast and Region, 2022 – 2030”

LOS ANGELES, Jan. 16, 2023 (Globe Newswire) — World Neurocoagulation Devices Market The volume reached US$ 730 million in 2021 and is expected to achieve a market size of US$ 1,227 million by 2030 at a CAGR of 6.3% from 2022 to 2030

Thrombophlebectomy Devices market statistics

  • Global Thrombectomy Devices Market Revenue reached USD 730 Million in 2021, at a CAGR of 6.3% between 2022 and 2030

  • Europe’s Neurophlebectomy Devices market share amassed over 32.2% in 2021

  • By product, clot recovery segment accounted for more than 58% of the total market share in 2021

  • Medtronic is a leading manufacturer of neurophlebectomy devices, offering a wide range of stroke treatment tools such as the Solitaire stent Retever, Trevo ProVue device and Trevo XP

  • Increasing adoption of minimally invasive therapy is fueling the market value of neurocoagulation devices

Request for a free sample report @

Vascular Venous Ablation Devices Market Report Coverage:


Neurocoagulation Devices Market

Neurocoagulation Devices Market Size 2021

730 million US dollars

Neurocoagulation Devices Market 2030 forecast

1,227 million US dollars

Neurocoagulation Devices Market Compound annual growth rate during 2022 – 2030


Neurocoagulation Devices Market analysis period

2018 – 2030

Neurocoagulation Devices Market base year


Neurocoagulation Devices Market forecast data

2022 – 2030

Covered slices

By product, use and geography

Neurocoagulation Devices Market regional scope

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Profile of the main companies

Abbott, Acandis GmbH, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic, Penumbra Inc. , Phenox GmbH, Stryker Corporation, and Vesalio.

report coverage

Market trends, drivers, restraints, competitive analysis, player classification, regulation analysis

Thrombophlebectomy Devices market overview

Neurocoagulant ablation devices enable patients to avoid or limit the use of pharmacological thrombolysis, thereby reducing the risk of intracerebral hemorrhage (ICH). These can be used outside of the time restrictions imposed by rtPA. These drugs may lead to recanalization faster than thrombolytic drugs, as well as fibrinolytic thrombolytic therapy alternatives. The increasing number of strokes worldwide is increasing the need for neural thrombectomy equipment in the healthcare industry. For example, the World Health Organization (WHO) estimates that 15.2 million people died from strokes worldwide in 2016. Increased knowledge of the benefits and applications of these technologies is also contributing to their expansion.

Neurocoagulation devices market trends

The Neurophlebectomy Devices Market is a rapidly growing industry in the medical device industry, driven by various aspects such as increasing incidence of stroke, population aging, and technological improvements. Population aging is a major driver of the neurocoagulation device industry. As people get older, their chance of having a stroke increases, and they are more likely to have severe strokes that require procedures such as thrombectomy. This trend from generation to generation leads to an increase in the demand for neurocoagulation devices.

Rising incidence of stroke is another important driver of the neuroleptic lung ablation devices market. Stroke is the second leading cause of death in the world and a leading cause of disability, according to the World Health Organization (WHO). As the incidence of stroke continues to increase, so does the demand for neuroleptic ablation devices. The increasing use of minimally invasive procedures is also driving an expansion of the market. Minimally invasive procedures offer various advantages over standard open surgery, including faster recovery times, less pain, and less potential for problems.

Check out the detailed table of contents of the report @

Thrombophlebectomy devices market segmentation

The global thrombophlebectomy devices market has been segmented by Acumen Research and Consulting on the basis of product and end use.

  • Based on product, the market is segmented into clot retrieval devices, aspiration/suction devices, as well as vascular decoys. According to the forecasts of the neurophlebectomy devices market, the aspiration/suction device category is expected to develop significantly in the next few years.

  • Based on the end user, the market is categorized into emergency clinics, research institutes, hospitals, laboratories as well as ambulatory surgical centres. According to the analysis, the global market is dominated by the hospital segment. The increasing number of hospitals, particularly in developing countries around the world, is boosting the segmental market value. Patients’ willingness to receive treatment for brain disorders in hospitals due to the presence of trained professionals and appropriate technical assistance in terms of equipment also adds to the segment’s market value.

Overview of the Neurophlebectomy Devices Market

On the basis of region, the worldwide Neurophlebectomy Devices market is segmented into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to the Neurophlebectomy Devices industry analysis, Europe is expected to occupy the majority of the market throughout the forecast period. The presence of major companies in the region greatly supports the growth of the market in the region, as companies are constantly trying to increase their market share. Major companies’ continuous investment in R&D to create new and better products that can eliminate limitations or give more relevant attributes is also expected to boost the growth of the regional market.

Besides, the Asia Pacific region is expected to grow over the forecast period. The region’s fast-growing economies, especially China and India, are boosting regional market value. The economic expansion of the medical infrastructure in the region also contributed to its growth. The value of the regional market is increasing as a result of positive government support and changing customer lifestyles.

Buy this premium research report –

Neurocoagulation Devices Market

Some of the prominent companies in the neural thrombolysis device market are Medtronic, Edwards Lifesciences Corporation, Abbott, Boston Scientific Corporation, Phenox GmbH, Stryker Corporation, Vesalio, and Penumbra Inc. and Acandis GmbH. To strengthen its position in the thrombectomy device business, these companies have announced mergers and acquisitions, partnerships, partnerships and new product development. Big companies are also expanding into new markets using modern technology in order to gain a competitive advantage in the near future.

Some of the key strategies related to the Neurophlebectomy Devices industry include:

  • In 2019, Medtronic plc launched the 4th generation Solitaire X revascularization machine to the market. This device is intended for use in the treatment of acute ischemic stroke (AIS).

  • In 2019, Vesalio revealed that it had obtained a second CE mark license covering many of NeVa’s design concepts and technologies for nerve thrombectomy. The new generation of NeVa tool improves on Drop Zone and Smart Marker innovations while introducing first-to-market features such as the Remote Filter.

  • Ceretrieve, which has developed a unique thromboembolic device with integrated anastomotic protection for complete clot retrieval, has been awarded $1.5 million to enhance clinical outcomes in stroke patients with a next-generation suction catheter. In January 2021, Amir Bilson, Managing Director, will join the company as President.

  • Stryker presented the Sonopet iQ Ultrasonic Aspirator System at the American Association of Neurological Surgeons Annual Meeting in San Diego. This technology aims to improve accuracy while increasing speed and power for greater ease of use.

Browse more search topic at Reports related to the healthcare sector:

Globalism neurosciences market Size is evaluated 10,796 million US dollars In 2021 it is expected to arrive 34.761 million US dollars By 2030, with a large proportion 14.3% compound annual growth rate From 2022 to 2030.

Globalism Sleep technology market Size is evaluated 15407 million US dollars In 2021 it is estimated to reach a value 60,955 million US dollars By 2030, it is growing at a rate A compound annual growth rate of 16.8% From 2022 to 2030.

Globalism Tubeless insulin pump market Size is calculated for $1,066 million USD In 2021 it is expected to reach the market value of 6,027 million US dollars By 2030, it is growing at a rate 21.7% compound annual growth rate From 2022 to 2030.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market information and advisory services for the information technology, investment, telecom, manufacturing and consumer technology markets. ARC helps the investment communities, IT professionals, and entrepreneurs make fact-based decisions about technology purchases and develop company growth strategies to stay competitive in the marketplace. With a team size of over 100 analysts and collective industry experience of more than 200 years, Acumen Research and Consulting is guaranteed to deliver a blend of industry knowledge along with expertise at both global and country levels.

For the latest update follow us on Twitter And Instagram And linkedin

call us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +134 74743864

India: +918983225533


Leave a Comment